Summer is heating up — and so are our innovation study results. Read on to learn how your company compares in R&D and discover new sources of innovation.
We're also serving up the latest in VA lab breakthroughs available to license today. From a novel kidney disease treatment to a tool that reduces foodborne illnesses, these world-changing inventions offer the next wave of healthcare advances.
The machinery industry is vast, spanning industrial machines, medical equipment, commercial kitchen gear and more. Due to its complexity, this industry differs from others in several key ways:
Machinery makers are more likely to have innovation strategies addressing all corporate departments — 33% versus just 22% of companies in other industries.
But, they invest less in R&D than companies in other industries. Just 38% of machinery makers invest more than 10% of sales in R&D.
Are you looking to improve your innovation efforts? Our R&D Innovation Performance Study is designed to help you. Read the machinery industry findings to learn more.
Researchers at Northport VA Medical Center have developed a groundbreaking treatment to address chronic kidney disease — a condition affecting over 37 million U.S. adults that poses significant risks like stroke and heart attacks.
This new class of small-molecule compounds could reshape how we prevent and treat kidney disease by enhancing kidney cell functions, potentially leading to better patient outcomes.
Could your company develop this treatment for widespread use?
Propellers are essential for water vehicles and wind energy systems, but less-than-optimal conditions, such as environmental factors or increased drag, can pose challenges.
A new automatic passive variable pitch propeller from the Naval Undersea Warfare Center adjusts pitch based on speed, optimizing performance across various conditions. It's lightweight, simple, and efficient, offering benefits for submarines, drones, and renewable energy systems.
Details about an opportunity to license this technology are on our site.
Heart failure affects 64 million people worldwide. Advanced therapy, such as cardiac resynchronization therapy or an implantable cardioverter defibrillator, has reduced deaths in one heart failure subtype (HFrEF). However, administering those types of therapy to patients with another subtype (HFpEF) can instead have adverse effects.
To help medical staff more accurately identify heart failure subtypes in patients, VA researchers have developed an algorithm that shows the genetic difference in subtypes. Better diagnoses leads to faster and more effective therapeutic outcomes.
Interested in licensing this technology for practical application?
Foodborne illnesses impact one in six people every year. About 100,000 of these individuals will be hospitalized, and as many as 3,000 may die. The pathogens that cause these illnesses often hide in crevices and joints of food preparation surfaces.
Army scientists invented the Sonic Swab, a handheld device that removes microbiological matter like pathogens using an ultrasonic vibration. The process not only reduces food contamination, but it also collects pathogens for further analysis.
The biotech company SafetySpect has licensed the Sonic Swab to complement its Contamination and Sanitization Inspection (CSI) technology, a pathogen detection tool. Together, the tools will enable faster identification and removal of contaminants in food service areas.
Read the full story to learn the ways federal technology transfer has fueled SafetySpect's business.
